Compounds derived from alkyl phenyl 4 (3H) - piperazino ona； Pharmaceutical Composition and its use for the treatment of disorders associated with serotonergic receptor 5-ht1a and 5-ht2a,Such as Depression, anxiety, and Sleep Disorders.
ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A.;ACHÉ INTERNATIONAL (BVI) LTD.
发明人:
FREIRE TORRES RUSSO, VALTER,MANNOCHIO DE SOUZA RUSSO, ELISA
申请号：
CL2012003539
公开号：
CL2012003539A1
申请日:
2012.12.14
申请国别(地区):
CL
年份:
2013
代理人:
摘要：
T. Present invention of lt； P gt； oacute； n EST Aacute； relates to F amp 4 (3H) quinazolinona compound； oacute； RMB general (I),Pharmacists and amperes； oacute； tragically, being proactive and able to act on HIV / AIDS patients and amperes； eacute； rgicos 5-HT1A and 5-HT2A to promote control, mitigation or treatment of disorders associated with these patients； and pharmacology and amphetamine synthesis； eacute； Compounds used to treat disorders associated with these receptors. These compounds and their components are: potency and amp； ikat； potency and amp； uacute； treatment of depression and amp； oacute； N, anxiety, phobia, addiction, aggression, impulsivity, P amp； Aacute； Nico, food, Sue amp； ntilde； O, PSIC amp； oacute； obsessive-compulsive disorder, female sexual dysfunction,Other issues related to these receivers； lt； / P gt；<；p>；LA PRESENTE INVENCIÓ；N ESTÁ； RELACIONADA CON LOS COMPUESTOS DE ALQUIL-PIPERAZINO-FENIL 4(3H)QUINAZOLINONA DE FÓ；RMULA GENERAL (I), FARMACOLÓ；GICAMENTE ACTIVOS Y CAPACES DE ACTUAR SOBRE LOS RECEPTORES SEROTONINÉ；RGICOS 5-HT1A Y 5-HT2A DE FORMA DE PROMOVER EL CONTROL, ALIVIO O LA CURA DE TRASTORNOS ASOCIADOS A ESTOS RECEPTORES Y, A LAS COMPOSICIONES FARMACÉ；UTICAS QUE CONTIENEN LOS COMPUESTOS PARA EL TRATAMIENTO DE TRASTORNOS ASOCIADOS A ESTOS RECEPTORES. ESTOS COMPUESTOS Y SUS COMPOSICIONES FARMACÉ；UTICAS SON Ú；TILES EN EL TRATAMIENTO DE TRASTORNOS DE DEPRESIÓ；N, ANSIEDAD, FOBIAS, ADICCIONES, AGRESIVIDAD, IMPULSIVIDAD, PÁ；NICO, ALIMENTARIOS, DEL SUEÑ；O, PSICÓ；TICOS, TRASTORNO OBSESIVOCOMPULSIVO, DISFUNCIONES SEXUALES FEMENINAS, ENTRE OTROS TRASTORNOS ASOCIADOS A ESTOS RECEPTORES.<；/p>；
